Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells
✍ Scribed by Luisa Salvatori; Francesca Caporuscio; Giuseppe Coroniti; Giuseppe Starace; Luigi Frati; Matteo Antonio Russo; Elisa Petrangeli
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 446 KB
- Volume
- 220
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In previous studies on HeLa cells we demonstrated estrogen‐responsiveness of the epidermal growth factor receptor (EGFR) gene, as 17β‐estradiol (E~2~) and selective estrogen receptor modulators (SERMs) genistein (G), daidzein (D), and 4‐hydroxytamoxifen (4OH‐T) modulated its transcription in a ligand‐ and estrogen receptor (ER) isoform‐specific way. This study describes further investigations into the role of ERs in mediating the effects induced by E~2~ and SERMs on EGFR expression, and the relationship between the actions of ERs and EGFR in U2OS osteosarcoma cells stably expressing ERα or ERβ. Cell number and DNA content determination revealed that E~2~, G, and D inhibited proliferation and cell cycle progression and promoted apoptosis in both cell lines. In parallel, changes in cell morphology typical of osteoblast maturation were observed via optical microscopy. Consistently, quantitative PCR and Western blot analysis showed an up‐regulation of markers of osteoblast differentiation and bone repair, and a decrease in EGFR expression. The transfection of specific antisense (AS) oligonucleotides strengthened our hypothesis that EGFR reduction caused changes in the proliferation/differentiation pattern comparable to those induced by ER ligands. The link between the ER and EGFR pathways was confirmed by treatment with 4OH‐T, which decreased the EGFR level and produced differentiation effects via ERα, but induced both EGFR expression and proliferation effects via ERβ. In conclusion, we show that also in U2OS cells, E~2~ and SERMs are able to modulate the expression of the EGFR gene and can affect events strictly controlled by its signaling pathway, such as the maturation of osteoblasts. J. Cell. Physiol. 220: 35–44, 2009. © 2009 Wiley‐Liss, Inc.